Bullets:
Stem Cell researchers now are focused on umbilical cord tissues as the most promising source for the cells.
Cord blood stem cells are younger, healthier, and more adaptable. Doctors are now treating patients with severe brain and spinal trauma, along with a wide range of degenerative diseases and cancers with MSC cells from umbilicals.
China's umbilical stem cell industry now leads the world, with nearly as many clinical applications as the rest of the world combined.
The Chinese healthcare system is open to foreigners, and its stem cell research centers in Shenzhen, Shanghai, and Shenyang already attract thousands of patients from abroad.
Closing scene, Yacht Marina, Sanya, Hainan
Resources and links:
中国自体脐血应用呈上升趋势，自体脐血应用前景广阔 https://www.gdcordblood.org/xkxw/info_136.aspx?itemid=6578
Cord Blood Utilization is Booming in China To learn more about cord blood banking, visit Parent's Guide to Cord Blood Foundation https://parentsguidecordblood.org/en/news/cord-blood-utilization-booming-china
Umbilical cord-derived mesenchymal stem cells: Their advantages and potential clinical utility
https://pmc.ncbi.nlm.nih.gov/articles/PMC3999777/
Stem Cells in the Umbilical Cord
https://pmc.ncbi.nlm.nih.gov/articles/PMC3753204/
Umbilical Cord-derived Mesenchymal Stem Cells https://synapse.patsnap.com/drug/fb25dac338094d37bbea17bb596d7357?
'Cell replacement' therapy shows potential in improving functional recovery of Parkinson's disease patients https://www.chinadaily.com.cn/a/202504/10/WS67f75f71a3104d9fd381e922.html
The first Chinese patient treated for Parkinson's disease with an innovative therapy at Ruijin Hospital can now walk on her own https://www.shsmu.edu.cn/english/info/1021/5111.htm
Stem cell therapy for Parkinson’s disease approved for Phase 1 trials https://parkinsonsnewstoday.com/news/stem-cell-therapy-parkinsons-disease-approved-phase-1-trials/
World's First -- XellSmart's Allogeneic iPSC-derived Regenerative Cell Therapy for Spinal Cord Injury Officially Approved by the U.S. FDA for a Registrational Phase I Clinical Trial
https://www.prnewswire.com/news-releases/worlds-first--xellsmarts-allogeneic-ipsc-derived-regenerative-cell-therapy-for-spinal-cord-injury-officially-approved-by-the-us-fda-for-a-registrational-phase-i-clinical-trial-302464016.html
XellSmart's Allogeneic iPSC-derived Cell Therapies for Parkinson's Disease and ALS Officially Approved by the U.S. FDA for Phase I Clinical Trials https://www.prnewswire.com/news-releases/xellsmarts-allogeneic-ipsc-derived-cell-therapies-for-parkinsons-disease-and-als-officially-approved-by-the-us-fda-for-phase-i-clinical-trials-302427583.html
Where Are Mesenchymal Stem Cells (MSCs) Found in the Body? https://celltexbank.com/blog-msc-tissue-sources/
FETAL IMPLANTS YIELD DISAPPOINTING RESULTS WITH PARKINSON TREATMENT https://journals.lww.com/neurotodayonline/fulltext/2001/05000/fetal_implants_yield_disappointing_results_with.20.aspx
Umbilical cord stem cells: Background, processing and applications https://www.sciencedirect.com/science/article/abs/pii/S0040816619305270 2024
Update on Cord Blood Utilization in China and Comparison to Other Countries To learn more about cord blood banking, visit Parent's Guide to Cord Blood Foundation https://parentsguidecordblood.org/en/news/2024-update-cord-blood-utilization-china-and-comparison-other-countries
Share this post